Hollviken, Sweden

Carina Vingsbo-Lundberg



 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Höllviken, SE (2011)
  • Hollviken, SE (2012 - 2014)

Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Carina Vingsbo-Lundberg: Innovator in Tuberculosis Vaccine Development

Introduction

Carina Vingsbo-Lundberg is a prominent inventor based in Hollviken, Sweden. She has made significant contributions to the field of immunology, particularly in the development of tuberculosis vaccines. With a total of four patents to her name, her work focuses on innovative solutions for preventing and treating tuberculosis infections.

Latest Patents

Among her latest patents, Carina has developed immunogenic compositions, vaccines, and pharmaceutical compositions aimed at preventing, boosting, or treating infections caused by species of the tuberculosis complex. One notable invention involves a fusion polypeptide that includes one or more starvation antigens. This composition can be administered alongside BCG, either mixed or separately, to enhance the immunogenic response.

Career Highlights

Carina is currently associated with the Statens Serum Institut, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding and treatment of tuberculosis, a disease that remains a significant global health challenge.

Collaborations

Throughout her career, Carina has collaborated with esteemed colleagues such as Claus Aagaard and Peter Andersen. These partnerships have further enriched her research and contributed to the success of her innovative projects.

Conclusion

Carina Vingsbo-Lundberg stands out as a dedicated inventor in the field of tuberculosis vaccine development. Her innovative approaches and collaborative efforts are paving the way for advancements in immunology and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…